- Research works
- 25 ▲ 5% vs 2013–17
- Citations
- 545 21.8 per fractional work
- Top-10% rate
- 23.5% record average 16.5%
- Open access
- 59% world 28%
Not ranked overall: Janssen (Ireland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.9×. Every wedge is a field page.
Which keywords describe research at Janssen (Ireland)?
By fractional works in all years, weighted toward what it does more of than the world: Aging, Alzheimer's Disease, Caregiver Burden, Neuroimaging, Biomarkers, Dementia, Mild Cognitive Impairment and Quality of Life.
- Epidemiology
- Antidepressant
- Minimal Residual Disease
- Clinical Guidelines
- Quality of Life
- Dementia
- Biomarkers
- Alzheimer's Disease
- Aging
- Caregiver Burden
- Neuroimaging
- Mild Cognitive Impairment
- Depression
- Prognostic Factors
- Rituximab
- Cognitive Impairment
- Ketamine
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Aging3▲ 25×3 topics
- Alzheimer's Disease3▲ 47×2 topics
- Caregiver Burden3▲ 153×2 topics
- Biomarkers3▲ 18×2 topics
- Neuroimaging3▲ 39×2 topics
- Dementia3▲ 152×1 topic
- Mild Cognitive Impairment3▲ 174×1 topic
- Quality of Life2▲ 7.0×7 topics
- Depression2▲ 9.1×7 topics
- Clinical Guidelines1▲ 18×3 topics
- Prognostic Factors1▲ 11×4 topics
- Minimal Residual Disease1▲ 75×2 topics
- Rituximab1▲ 30×2 topics
- Antidepressant1▲ 152×1 topic
- Cognitive Impairment1▲ 19×2 topics
- Epidemiology1◆ 1.08×8 topics
- Ketamine1▲ 152×1 topic
Which research topics does Janssen (Ireland) publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, Treatment of Major Depression, CAR-T cell therapy research and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and Treatments Hematology 1 works
- 2 Treatment of Major Depression Pharmacology 1 works
- 3 CAR-T cell therapy research Oncology 0 works
- 4 Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Experimental and Cognitive Psychology 0 works
- 5 Protein Degradation and Inhibitors Molecular Biology 0 works
- 6 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 7 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
- 8 Psoriasis: Treatment and Pathogenesis Immunology 0 works
- 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 10 Tryptophan and brain disorders Biological Psychiatry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Janssen (Ireland)'s research output changed?
Output in 2018–2022 was 5% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dublin
- University College Dublin
- Trinity College Dublin
- Dublin City University
- Royal College of Surgeons in Ireland
- St. James's Hospital
- St. Vincent's University Hospital
- Technological University Dublin
- National University of Ireland
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.